Medicine

®

Retraction

OPEN

A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury: Retraction The article, “A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury”,[1] which appeared in Volume 96, Issue 20 of Medicine, has been retracted for plagiarism and academic fraud. Similar design study, language, and tables were found in a previously published article, “Botulinum toxin type A for neuropathic pain in patients with spinal cord injury”,[2] which appeared in Volume 79, Issue 4 of Annals of Neurology, without any attribution or citation.

References [1] Li G, Lv C, Tian L. A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury. Medicine. 96;20: e6919. [2] Han Z, Song D-H, O H-M. Botulinum toxin type A for neuropathic pain in patients with spinal cord injury. Annals of Neurology. 79;4:569–578.

Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Medicine (2017) 96:33(e7871) http://dx.doi.org/10.1097/MD.0000000000007871

1